INIS
nervous system diseases
100%
patients
80%
symptoms
47%
risks
40%
brain
30%
people
30%
reviews
27%
psychoses
24%
interventions
24%
control
23%
data
22%
comparative evaluations
20%
adults
20%
assessments
19%
levels
19%
therapy
14%
performance
12%
populations
12%
quality of life
11%
biological markers
11%
sampling
11%
diseases
10%
genetics
10%
nmr imaging
10%
evaluation
9%
design
9%
cerebrospinal fluid
9%
spectra
8%
information
8%
children
8%
processing
8%
pathology
7%
psychological behavior
7%
stimulation
7%
values
7%
genes
7%
prediction
6%
interactions
6%
communities
6%
netherlands
6%
volume
6%
validation
6%
motors
6%
dopamine
5%
size
5%
learning
5%
sex
5%
adolescents
5%
cost
5%
recommendations
5%
screening
5%
hospitals
5%
Keyphrases
Alzheimer's Disease
21%
Dementia
20%
22q11.2 Deletion Syndrome
17%
Parkinson's Disease
16%
Psychosis
15%
Mild Cognitive Impairment
15%
Schizophrenia
11%
Experience Sampling
10%
Depressive Symptoms
10%
Quality of Life
10%
Young Onset Dementia
10%
People with Dementia
9%
Meta-analysis
8%
Maastricht
8%
Healthy Controls
8%
Randomized Controlled Trial
8%
Psychotic Disorders
7%
Cognitive Decline
7%
Memory Clinic
7%
Neuropsychiatric Symptoms
7%
Caregivers
7%
Cognitive Impairment
7%
Cerebrospinal Fluid
7%
Netherlands
7%
Dutch
7%
Daily Life
6%
Deep Brain Stimulation
6%
Informal Caregivers
5%
Risk Factors
5%
Cognitive Performance
5%
Psychiatric Disorders
5%